The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Matching degree between PI3K/AKT/mTOR (PAM) pathway mutations (mut) and therapy (ttx) as predictor of clinical benefit (ClinBen) in early trials.
 
Juan Martin Liberal
No Relationships to Disclose
 
Ana Maria Martinez de Castro
No Relationships to Disclose
 
Rodrigo Dienstmann
No Relationships to Disclose
 
Cinta Hierro
No Relationships to Disclose
 
Maria Ochoa de Olza
No Relationships to Disclose
 
Irene Brana
No Relationships to Disclose
 
Analia Azaro
No Relationships to Disclose
 
Guillem Argiles
Travel, Accommodations, Expenses - Bayer
 
Cristina Cruz Zambrano
No Relationships to Disclose
 
Mafalda Oliveira
Research Funding - AstraZeneca
 
Cristina Saura
No Relationships to Disclose
 
Ana Oaknin
No Relationships to Disclose
 
Helena Aguilar
No Relationships to Disclose
 
Elena Sanchez
No Relationships to Disclose
 
Paolo Nuciforo
No Relationships to Disclose
 
Ana Vivancos
No Relationships to Disclose
 
Josep Tabernero
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Celgene; Chugai Pharma; ImClone Systems; Lilly; Merck; Merck Serono; Millennium; Novartis; Roche/Genentech; Sanofi; Symphony Evolution; Taiho Pharmaceutical
 
Jordi Rodon Ahnert
No Relationships to Disclose